San Francisco anti-aging firm seeks $85 million for clinical trials using Mayo intelligence.
The medical device giant expects the deal could one day be huge, entering it into a market valued between $500 million and $2 billion.
Use of ‘liquid biopsies’ to track disease progression found to be feasible.
The sleep apnea device maker is the sixth company out of Minnesota this year to register for an initial public offering.
The university’s Clinical and Translational Science Institute, which helps support research in various behind-the-scenes ways, awarded funds from the National Institutes of Health.
The funds will aid in commercialization of wearable technology geared toward improving balance and preventing falls.
Securus makes an advanced thermal monitoring system that can display the temperature of the esophagus during cardiac ablation procedures.
The respiratory device company informed Minnesota state officials of the decision, as legally required by the WARN Act.
The Rochester firm will hire up to 30 new workers as it completes a new headquarters build-out.